CTLA4 and myeloid sarcoma: Consistent with this finding, compared to healthy controls, lower surface and higher intracellular expression of CTLA-4 in CD4+CD25+ T cells were found in MS patients, and these were correlated with the levels of FoxP3 mRNA (96).